Amnesia
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.
|
29724592 |
2018 |
Memory impairment
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.
|
29724592 |
2018 |
Frontotemporal dementia
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.
|
29724592 |
2018 |
Memory Impairment, CTCAE 3.0
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.
|
29724592 |
2018 |
Blood Protein Measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genomic atlas of the human plasma proteome.
|
29875488 |
2018 |
Memory dysfunction
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.
|
29724592 |
2018 |
Stem Cell Factor Measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide Association Study Identifies 27 Loci Influencing Concentrations of Circulating Cytokines and Growth Factors.
|
27989323 |
2017 |
Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site
|
0.040 |
Biomarker
|
disease |
BEFREE |
Combining these enzymes with Helicobacter pylori α1-3-fucosyltransferase, we develop a host-cell-based assay to probe glycan-mediated influenza A virus (IAV) infection including wild-type and mutant strains of H1N1 and H3N2 subtypes.
|
30996301 |
2019 |
Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site
|
0.040 |
Biomarker
|
disease |
BEFREE |
Biochemical characterization of Helicobacter pylori α1-3-fucosyltransferase and its application in the synthesis of fucosylated human milk oligosaccharides.
|
31132553 |
2019 |
Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site
|
0.040 |
Biomarker
|
disease |
BEFREE |
Production of 3-Fucosyllactose in Engineered Escherichia coli with α-1,3-Fucosyltransferase from Helicobacter pylori.
|
30927489 |
2019 |
Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site
|
0.040 |
Biomarker
|
disease |
BEFREE |
First, comparisons of various exogenous α1,2-fucosyltransferase and α1,3-fucosyltransferase candidates, as well as a series of E. coli host strains, demonstrated that futC and futA from Helicobacter pylori using BL21(DE3) as the host strain yielded the highest titers of 2'-FL and 3-FL.
|
28286292 |
2017 |
Carcinoma of lung
|
0.020 |
Biomarker
|
disease |
BEFREE |
alpha-2,3-Sialyltransferase type 3N and alpha-1,3-fucosyltransferase type VII are related to sialyl Lewis(x) synthesis and patient survival from lung carcinoma.
|
9128982 |
1997 |
Carcinoma of lung
|
0.020 |
Biomarker
|
disease |
BEFREE |
To examine the role of alpha-1,3-fucosyltransferase in the synthesis of sialyl Lewis x and the prognosis of lung cancer, PCR amplification of five fucosyltransferase genes and immunohistochemical staining of sialyl Lewis x were performed in 333 patients with lung cancer who underwent surgical resection from 1980 to 1993.
|
8542587 |
1996 |
Influenza A
|
0.010 |
Biomarker
|
disease |
BEFREE |
Combining these enzymes with Helicobacter pylori α1-3-fucosyltransferase, we develop a host-cell-based assay to probe glycan-mediated influenza A virus (IAV) infection including wild-type and mutant strains of H1N1 and H3N2 subtypes.
|
30996301 |
2019 |
Liver carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
After the transfection of alpha-1,3-fucosyltransferase (FucT)-VII cDNA into H7721 human hepatocarcinoma cells, the protein expression of some cyclins, cyclin-dependent kinases (CDKs) and cyclin-dependent kinase inhibitors (CDIs) p16INK4 and p21waf1/Cip1 were unchanged.
|
15666088 |
2005 |
Neoplasm Metastasis
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
These results provide target validation for inhibition of carcinoma metastasis with antisense FUT sequences and confirm the primacy of alpha(1,3)fucosyltransferases in the synthesis of selectin ligands.
|
10232599 |
1999 |
Secondary malignant neoplasm of liver
|
0.010 |
Biomarker
|
disease |
BEFREE |
Expression of human alpha(1,3)fucosyltransferase antisense sequences inhibits selectin-mediated adhesion and liver metastasis of colon carcinoma cells.
|
10232599 |
1999 |
Malignant neoplasm of lung
|
0.010 |
Biomarker
|
disease |
BEFREE |
To examine the role of alpha-1,3-fucosyltransferase in the synthesis of sialyl Lewis x and the prognosis of lung cancer, PCR amplification of five fucosyltransferase genes and immunohistochemical staining of sialyl Lewis x were performed in 333 patients with lung cancer who underwent surgical resection from 1980 to 1993.
|
8542587 |
1996 |
Adenocarcinoma of colon
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Elevation of an alpha(1,3)fucosyltransferase activity correlated with apoptosis in the human colon adenocarcinoma cell line, HT-29.
|
8981094 |
1996 |
Primary malignant neoplasm of lung
|
0.010 |
Biomarker
|
disease |
BEFREE |
To examine the role of alpha-1,3-fucosyltransferase in the synthesis of sialyl Lewis x and the prognosis of lung cancer, PCR amplification of five fucosyltransferase genes and immunohistochemical staining of sialyl Lewis x were performed in 333 patients with lung cancer who underwent surgical resection from 1980 to 1993.
|
8542587 |
1996 |